SAN
81.95
+1.6%↑
UCB
262.1
+1.67%↑
SHL.DE
38.94
+1.54%↑
ARGX
717.6
+0.96%↑
VIE
35.55
+0.74%↑
SAN
81.95
+1.6%↑
UCB
262.1
+1.67%↑
SHL.DE
38.94
+1.54%↑
ARGX
717.6
+0.96%↑
VIE
35.55
+0.74%↑
SAN
81.95
+1.6%↑
UCB
262.1
+1.67%↑
SHL.DE
38.94
+1.54%↑
ARGX
717.6
+0.96%↑
VIE
35.55
+0.74%↑
SAN
81.95
+1.6%↑
UCB
262.1
+1.67%↑
SHL.DE
38.94
+1.54%↑
ARGX
717.6
+0.96%↑
VIE
35.55
+0.74%↑
SAN
81.95
+1.6%↑
UCB
262.1
+1.67%↑
SHL.DE
38.94
+1.54%↑
ARGX
717.6
+0.96%↑
VIE
35.55
+0.74%↑
24h
Current
Min
102.8
Max
106.3
Income | -82M -235M |
|---|---|
Sales | -2M -2M |
Profit margin | 11,666.733 |
Employees | 69 |
EBITDA | -62M -156M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +20.66% upside |
Next Earnings | 25 maj 2026 |
|---|
Market Cap | 1.4B 8.4B |
|---|---|
Previous open | 103.03 |
Previous close | 104.2 |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
12 sty 2026, 11:10 UTC
Correction to Eli Lilly Headline
DJ
Read
12 sty 2026, 10:10 UTC
Abivax Surges on Report Ely Lily is Preparing $17.5 Billion Bid
DJ
Read
22 gru 2025, 15:28 UTC
Abivax Shares Jump on Eli Lilly Takeover Report
DJ
Read
12 sty 2026, 18:20 UTC
This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com
DJ
Read
12 sty 2026, 17:27 UTC
This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com
DJ
Read
12 sty 2026, 14:51 UTC
This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com
DJ
Read
12 sty 2026, 14:39 UTC
Stocks to Watch Monday: Capital One, UnitedHealth, Walmart, Exxon -- WSJ
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 125 EUR 20.66%
High 130 EUR
Low 120 EUR
Based on 2 Wall Street analysts offering 12 month price targets forAbivax SA - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Abivax SA - Dist in the past 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$